Carla Mozee SAN FRANCISCO (MarketWatch) -- Vivus Inc. said Thursday that results from a Phase II study evaluating the safety and efficacy of Testosterone Metered Dose Transdermal Spray, an ...

The metered-dose transdermal spray therapy is intended as treatment for Hypoactive Sexual Desire Disorder, a condition that Vivus VVUS said affects about 25 percent of women.

Virpax’s Patch-in-a-Can technology delivers pain medication using a metered-dose spray film. Virpax Pharmaceuticals is developing a Patch-in-a-Can metered-dose spray film technology for topical drugs ...

Evamist is a plant-based transdermal estrogen that is applied onto the skin by a metered-dose spray applicator. For more information call (877) 567-7676 or visit evamist.com.

Acrux has received notification of the grant of a US patent (number 6,978,945), which provides robust protection for its Metered Dose Transdermal Spray (MDTS®)applicator for delivery of drugs.

Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...

The transdermal estradiol spray joins the ranks of other appropriate, low-dose estrogen preparations as a safe and effective means of treating menopausal symptoms.

Vivus received FDA approval for the marketing of Evamist™, a metered dose transdermal estradiol spray for the treatment of moderate-to-severe vasomotor symptoms due to menopause. Evamist is the ...

The metered spray enables patients to apply a precise dose of testosterone for transdermal delivery. The applied dose dries in approximately 60 seconds and becomes invisible.

Estradiol 1.53 mg/spray; transdermal spray. The addition of exogenous estrogens helps to alleviate the vasomotor symptoms that are associated with declining estrogen levels.Evamist is designed to ...

The Population Council (New York, NY) and Acrux Pharmaceuticals (West Melbourne, Australia) have reported positive Phase I results for the first contraceptive spray for women. Results indicate that ...

Vivius has received FDA approval for the marketing of Evamist, a metered dose transdermal estradiol spray for the treatment of moderate to severe vasomotor symptoms due to menopause.